title: Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study.
authors.forename: G
authors.initials: G
authors.lastname: Bertoni
authors.forename: G
authors.initials: G
authors.lastname: Fornaciari
authors.forename: M
authors.initials: M
authors.lastname: Beltrami
authors.forename: R
authors.initials: R
authors.lastname: Conigliaro
authors.forename: M
authors.initials: M
authors.lastname: Grazia Mortilla
authors.forename: E
authors.initials: E
authors.lastname: Ricci
authors.forename: E
authors.initials: E
authors.lastname: Castagnetti
authors.forename: G
authors.initials: G
authors.lastname: Bedogni
authors.forename: A C
authors.initials: AC
authors.lastname: Plancher
mesh_terms: D000328:Adult; D000368:Aged; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol / Q000008:administration & dosage / Q000627:therapeutic use*; D010865:Pilot Projects; D011897:Random Allocation; D012008:Recurrence; D015911:Sclerotherapy
chemical_list: D009248:Nadolol